EU Commision New Rules For Auditing by NBs

The EU Commision published “COMMISSION RECOMMENDATIONof 24 September 2013 on the audits and assessments performed by notified bodies.

This clarifies and strengthens the criteria for certifying (and auditing) notified bodies and the criteria that the notified bodies have to use in assessing companies and products.

The main changes are that the member states are required to do a joint assessment of a potential notified body with experts from the Commission and to carry out surveillance and monitoring of notified bodies. It also requires notified bodies to do unannounced factory audits which they were not allowed to do before (but the FDA
does).

It also states “As publication of residual risks in the information given to the user does not reduce the risk, but publication of residual risks and warnings used as risk
control measure may be beneficial, have residual risks been correctly placed on IFUs or provided in training, and have manufacturers evaluated whether those warnings are effective…” This clarifies that although labeling cannot reduce risk labelling can still be used as risk control measures.

Upcoming Training

62304, FDA, and Emerging Standards for Medical Device and HealthIT
Instructors:  Brian Pate, John F. Murray, Jr
Location: Sunnyvale, CA, USA
Dates:  February 4-6, 2020
Registration Link

Receive $300 discount with Premium-Individual subscription purchase (or $333 per person for Premium-Company subscription)!  Email training@softwarecpr.com
to receive discount

QSS Software Validation
Planned Instructors:  Brian Pate, John F. Murray, Jr
Location: Boston, MA, USA
Dates:  June 2-4, 2020
Registration Link

Corporate Office

15148 Springview St
Tampa, FL 33624
USA
+1-781-721-2921
Partners located in the US (CA, FL, MA, MN) and Italy.